A new study indicates that vaccinating 12-year-old boys against the humanpapilloma virus (HPV) may be a cost-effective strategy for preventing oropharyngeal squamous cell cancer, a cancer that starts…
Source: Medical News Today
HPV vaccination of adolescent boys may be cost-effective for preventing oropharyngeal cancer
